Details about Margaret K. Kyle

Access statistics for papers by Margaret K. Kyle.

Last updated 2023-12-04. Update your information in the RePEc Author Service.

Short-id: pky20

Working Papers

2017

1. Is American Health Care Uniquely Inefficient? Evidence from Prescription Drugs
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (5)

2016

2. The More We Die, The More We Sell? A Simple Test of the Home-Market Effect
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (14)

2014

3. Intellectual Property Rights and Access to Innovation: Evidence from TRIPS
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (19)

2013

4. Competition and the Efficiency of Markets for Technology
   TSE Working Papers, Toulouse School of Economics (TSE) View citations (2)
   Also in IDEI Working Papers, Institut d'Économie Industrielle (IDEI), Toulouse (2013) View citations (6)

2011

5. Inefficiencies in technology transfer: theory and empirics
   CEPR Discussion Papers, C.E.P.R. Discussion Papers View citations (7)
6. Inefficiencies in the sale of ideas: theory and empirics
   Working Papers, HAL View citations (1)
7. Investments in Pharmaceuticals Before and After TRIPS
   CEPR Discussion Papers, C.E.P.R. Discussion Papers View citations (4)
   Also in NBER Working Papers, National Bureau of Economic Research, Inc (2009) View citations (10)
   See also Journal Article Investments in Pharmaceuticals Before and After TRIPS, The Review of Economics and Statistics, MIT Press (2012) View citations (73) (2012)

2007

8. Strategic Responses to Parallel Trade
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (17)
   See also Journal Article Strategic Responses to Parallel Trade, The B.E. Journal of Economic Analysis & Policy, De Gruyter (2011) View citations (36) (2011)

2006

9. Public & Private Spillovers, Location and the Productivity of Pharmaceutical Research
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (37)

2000

10. Did U.S. Bank Supervisors Get Tougher During the Credit Crunch? Did They Get Easier During the Banking Boom? Did It Matter to Bank Lending?
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (16)
    Also in Finance and Economics Discussion Series, Board of Governors of the Federal Reserve System (U.S.) (2000) View citations (2)
    See also Chapter Did US Bank Supervisors Get Tougher during the Credit Crunch? Did They Get Easier during the Banking Boom? Did It Matter to Bank Lending?, NBER Chapters, National Bureau of Economic Research, Inc (2001) View citations (33) (2001)

Journal Articles

2013

1. Intellectual Property Protection and the Geography of Trade
   Journal of Industrial Economics, 2013, 61, (3), 733-762 View citations (52)

2012

2. Investments in Pharmaceuticals Before and After TRIPS
   The Review of Economics and Statistics, 2012, 94, (4), 1157-1172 View citations (73)
   See also Working Paper Investments in Pharmaceuticals Before and After TRIPS, CEPR Discussion Papers (2011) View citations (4) (2011)

2011

3. Strategic Responses to Parallel Trade
   The B.E. Journal of Economic Analysis & Policy, 2011, 11, (2), 34 View citations (36)
   See also Working Paper Strategic Responses to Parallel Trade, NBER Working Papers (2007) View citations (17) (2007)

2007

4. Generic competition and market exclusivity periods in pharmaceuticals
   Managerial and Decision Economics, 2007, 28, (4-5), 491-502 View citations (54)
5. Pharmaceutical Price Controls and Entry Strategies
   The Review of Economics and Statistics, 2007, 89, (1), 88-99 View citations (148)

2006

6. The role of firm characteristics in pharmaceutical product launches
   RAND Journal of Economics, 2006, 37, (3), 602-618 View citations (47)

2004

7. Does locale affect R&D productivity? the case of pharmaceuticals
   FRBSF Economic Letter, 2004, (nov12)

2002

8. Deregulating Direct-to-Consumer Marketing of Prescription Drugs: Effects on Prescription and Over-the-Counter Product Sales
   Journal of Law and Economics, 2002, 45, (S2), 691-723 View citations (35)

Chapters

2019

1. The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals
   A chapter in Innovation Policy and the Economy, Volume 20, 2019, pp 95-123

2010

2. Public and Private Spillovers: Location and the Productivity of Pharmaceutical Research
   A chapter in Contributions in Memory of Zvi Griliches, 2010, pp 165-188 View citations (17)

2003

3. The Long Shadow of Patent Expiration. Generic Entry and Rx-to-OTC Switches
   A chapter in Scanner Data and Price Indexes, 2003, pp 229-267 View citations (30)

2001

4. Did US Bank Supervisors Get Tougher during the Credit Crunch? Did They Get Easier during the Banking Boom? Did It Matter to Bank Lending?
   A chapter in Prudential Supervision: What Works and What Doesn't, 2001, pp 301-356 View citations (33)
   See also Working Paper Did U.S. Bank Supervisors Get Tougher During the Credit Crunch? Did They Get Easier During the Banking Boom? Did It Matter to Bank Lending?, National Bureau of Economic Research, Inc (2000) View citations (16) (2000)

Software Items

1997

1. MATLAB/C code for GIG and BNLG common value auction specifications
   Matlab codes